After Recent Declines Now Could Be The Ideal Time To Buy Aviva plc, Prudential plc, Hargreaves Lansdown Plc And Standard Life Plc

Now could be a great time to buy Aviva plc (LON: AV), Prudential plc (LON: PRU), Hargreaves Lansdown PLC (LON: HL) and Standard Life Plc (LON: SL)!

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The recent market volatility has thrown up some great bargains. Companies like Aviva (LSE: AV), Prudential (LSE: PRU), Hargreaves Lansdown (LSE: HL) and Standard Life  (LSE: SL) are all cheaper now than they have been for a long time and are unlikely to be affected by China’s economic troubles. 

Long-term outlook

As two of the UK’s largest pension and long-term savings providers, Aviva and Standard Life are insulated from emerging market turbulence — slowing Chinese economic growth isn’t going to affect the demand for pensions here in the UK. 

Legal & General believes that over the next 15 years the value of savings in UK defined-contribution pension schemes will nearly quadruple to approximately £3.3tn. Standard Life and Aviva are well placed to capture an enormous share of this additional business. Standard Life is the leading provider of workplace pensions in the UK.

After recent declines, Aviva trades at an attractive forward P/E of 10.1 and the company’s shares support a dividend yield of 4.4%. In contrast, Standard Life trades at an expensive looking forward P/E of 17.9. However, City figures suggest that the company’s earnings will grow 54% this year. Based on these forecasts for growth, Standard Life’s shares currently trade at a PEG ratio of 0.3. 

Asian exposure

Prudential has outperformed almost all of its peers over the past five years. From June 2010 to date, the company’s shares have produced a total return of 23% per annum. Over the same period, earnings per share have roughly doubled, and the company has hiked its dividend payout by 70%. 

Prudential’s well-timed expansion into the Asian life insurance market has helped the group grow faster than its peers in the past, and despite regional economic worries, Asia should continue to be a growth driver for Prudential going forward. Indeed, demand for life insurance is set to grow by around 10% per annum within Asia during the next four years. 

City analysts currently expect Prudential’s earnings per share to grow 14% this year and a further 11% for 2016. What’s more, according to forecasts, Prudential is expected to hike its dividend payout by 10% per annum for the next two years. The company’s shares currently support a dividend yield of 2.8% and trade at a forward P/E of 12.8. 

UK demand 

Hargreaves Lansdown is one of the UK’s most recognisable asset administrators, and looks after more than £55bn of people’s investments and pensions. 

The company’s shares are a play on the wider market’s performance over the next few years. City analysts believe that if the markets head higher during 2016 and 2017, assets under administration could expand by 20% per annum. But a negative market performance could cost the company 10% per annum in client assets. 

With Hargreaves Lansdown’s future dependent on the direction of the market, the company’s current valuation might be too pricey for some. At present, Hargreaves Lansdown trades at a forward P/E of 32.7 and its shares support a dividend yield of 2.9%. 

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »